Summary.-The effects of adriamycin (Adr) on the solid-tumour model, hepatoma 3924A, and on critical organs of the host, were determined at intervals after single injections of 60 mg/M2 of the agent. A reduced rate of tumour growth was evident 4 days after treatment, continued to Day 11, and then returned to rates comparable to control values. On Day 11 tumour volumes of treated animals were 38% of control.
control values. On Day 11 tumour volumes of treated animals were 38% of control.
During the period of reduced growth, 3H-TdR incorporation into tumour DNA and percentage labelled tumour cells were less than control values. DNA concentration in tumour was not affected by drug treatment, which differs from observations made in other studies employing 5-fluorouracil (FU) . No evidence of significantly increased necrosis or fibrosis of the tumour was found after Adr. The Adr treatment caused loss of 60% of the tibial marrow by Day 4, as measured by total DNA content.
Marrow DNA recovered to control levels between Days 7 and 11. Incorporation of 3H-TdR into heart DNA was reduced more than 400/o during the first week after Adr treatment; enhanced incorporation was observed on Day 11, and control levels were attained by Day 17. No significant pathological evidence of cardiac toxicity was found 2-21 days after Adr but degeneration of myocardial cells and oedema was prominent at 14 weeks.
THE kinetics of recovery for tumour and host organs after treatment with 5-fluorouracil (FU) have recently been determined for the experimental solid-tumour system, hepatoma 3924A (Kovacs et al., 1975; Hopkins et al., 1976; Looney et al., 1976) and these data have been used in the design of an effective chemotherapyradiotherapy combination for this tumour . The present report summarizes data obtained for hepatoma 3924A and its host the ACI rat after treatment with adriamycin (Adr), a relatively new chemotherapeutic agent which is effective against a wide range of human neoplasms (Carter, 1975) . Evaluation of the effects of Adr has included determinations of changes in tumour volume, changes in DNA content and 3H-TdR incorporation for marrow, intestinal mucosa, heart and tumour, tumour TdR labelling indices and pathological evaluations of tumour and host organs. Haematological data were obtained for peripheral blood and, in other studies, liver-function tests were performed, to obtain as much clinically relevant information as possible in this evaluation of the effects of Adr on both the solid tumour and its host. Experimental.-At various times after injection of 60 mg/M2 Adr and 1 h prior to killing, groups of 3 rats each were injected i.p. with 50,Ci thymidine-(methyl)-3H (sp. act. 3 Ci/mmol). At killing, blood for WBC, haematocrit and haemoglobin determinations was taken by cardiac puncture under ether anaesthesia. The tumour, tibia, heart and a 4 cm length of intestine immediately distal to the pylorus were removed for biochemical and histologic evaluations. Tissue specimens were routinely fixed in neutral formalin, embedded in paraffin, sectioned, and stained with haematoxylin and eosin. In addition, Masson stain was used for tumour. Autoradiographs were prepared with Kodak NTB-2 after Feulgen staining. Slides were exposed for 3 Mweeks, then developed with Kodak D-19.
METHODS
The marrow Nas aspirated from the tibia with cold 0.90o NaCl. The 4 cm length of intestine was slit longitudinally and the mucosa stripped from the underlying muscle. Tumour and heart were chilled in cold 0-9 0 NaCl, weighed, and portions taken for determination of DNA and 3H counts in the DNA fractions. RNA was eliminated from all samples by alkaline hydrolysis followed by washing with cold 10% trichloroacetic acid.
DNA was extracted by heating at 90°C for 20 min with 500 trichloroacetic acid and was measured by the method of Burton (1956 was not altered by drug treatment (Fig.  2) . Tumour sections stained with haematoxylin and eosin showed no effect of the drug on tumour histology or necrosis. growth of hepatoma 3924A (Hopkins et al., 1977) . Neither the magnitude of the loss of marrow after Adr nor the timing of the recovery was appreciably affected by the presence of the tumour. Incorporation of 3H-TdR into marrow DNA was determined at intervals after drug administration, and is expressed in Fig. 4 . At longer times after 60 mg/M2 Adr both DNA content and specific activity of the DNA were depressed 25% or more relative to control (Table I) .
Haematological data
Changes in WBC concentrations in peripheral blood after the administration of Adr to animals with tumours are shown in Table II . WBC concentrations were depressed 30-40% below initial control values on Days 4, 7 and 11 after treatment. Hepatoma 3924A stimulates granulocytopoiesis in the ACI rat (Hopkins et al., 1977) accounting for the increasing WBC values for the controls and for treated animals after Day 11. Haemoglobin and haematocrit values are not shown, but were similar for drug-treated and control rats, with the greatest difference, observed on Day 7, being only 18%.
Intestinal mucosa DNA measurements revealed that the cellularity of the intestinal mucosa after i.p. injection of Adr was -20% below control level for 4 days, (Fig. 5A ). Incorporation of 3H-TdR into DNA was less than control at 24 h after treatment, then increased markedly to more than twice control values on Day 4 (Fig. 5B) . DNA accumulated after the episode of increased 3H-TdR incorporation, and remained elevated for the duration of the experi- (Table I) . 
Heart
In heart, inhibition of 3H-TdR incorporation into DNA, by more than 40%, was observed during the first week after Adr was given (Fig. 6A) . Enhanced incorporation was seen on Day 11, with return to control levels by Day 17. Average heart DNA content for drug-treated rats was not different from control, after adjusting for differences in animal weights (Fig. 6B ).
Rats injected with 60 mg/M2 Adr by i.v., s.c., or i.p. routes and killed 3, 8 or 12 weeks later, often showed increased 3H-TdR incorporation in heart DNA ( Table  I) . Incorporation was about twice that of control rats at these times.
Foci of myocardial-cell degeneration accompanied by convergence of phagocytic cells were occasionally seen in the histologic preparations from rats treated 2 to 21 days earlier with 60 mg/M2 Adr, and in control animals as well. However, in rats surviving this drug treatment for 14 weeks, the incidence of these pathological changes was much increased. Intestinal adhesions occur after Adr is given i.p. However, this does not compromise the validity of the acute-survival data in Fig. 7 since deaths related to intestinal adhesions begin to occur only after 6 weeks. These deaths can be avoided by using the i.v. or s.c. routes.
Another complication which can affect long-term toxicity data, and is independent of route of administration, is an effect of cytotoxic drugs on the continuously growing rodent incisor teeth. Zajicek (1976) has described the rodent incisortooth proliferon as the site of 5 cell populations proliferating in harmony. Drugs such as cyclophosphamide (Vahlsing, 1975) , FU (Hopkins, unpublished) and Adr perturb these populations, with the result that the incisors become overgrown and the rat cannot eat a pelleted diet. Clipping of the teeth and feeding powdered diet will prevent death from starvation. It is important that animal mortality from overgrown teeth be carefully eliminated from toxicity data since this is not a factor in the clinical use of these drugs.
DISCUSSION
Adriamycin binds to DNA, and this is believed to be responsible for its cytotoxic effects, although the exact mechanism remains unknown. Synthesis of both RNA and DNA is inhibited by the drug for in vitro cell cultures (Kim and Kim, 1972) and more recently, single and double DNAstrand breaks have been seen after treatment of intact cells with Adr (Byfield et al., 1977) . Others have noted the similar, but not identical, effects of Adr and radiation on cells (Belli and Piro, 1977) and the possible involvement of ribosomal RNA synthesis (Clarkson and Humphrey, 1977) .
The changes in tumour morphology and quantitative changes in tumour kinetics after Adr described here may be compared with changes in the same solid-tumour model after an equally effective dose of the proliferation-dependent cancerchemotherapeutic agent FU. In studies not detailed here, we found no significant, differences in mean tumour volumes of animals given 900 mg/M2 (150 mg/kg) FU or 60 mg/M2 Adr over a period of 16 days after treatment. The dose of Adr used in the present study is therefore equivalent to that of 5-FU (900 mg/M2) in previous studies, with respect to total perturbation of tumour growth. The TdR labelling index was above control values 2 days after Adr administration. This returned to control values by Day 4 and remained below the control unitl Day 16. The rate of DNA synthesis was also elevated on Day 2 but depressed from Day 4 until Day 16. The elevation of both the DNA specific activity and labelling index on Day 2 suggests a redistribution of cells within the cell cycle, with an increased proportion of cells in the "S" period, as occurs with FU (Kovacs et al., 1975) . The depression of both DNA specific activity and labelling indices between Day 4 and Day 16 could be the result of the direct effects of Adr on DNA synthesis, as well as a reduction of S-phase cells. Clarkson and Humphrey (1977) reported that Chinese hamster ovary cells treated in mid-S phase showed a dose-dependent progression delay which was also reflected in the rates of DNA replication in the subsequent S phase. For hepatoma 3924A, the percentage of labelled cells remain high up to 1 week after FU administration (Kovacs et al., 1975 (Hopkins and Looney, 1978) . The total tibial DNA content has been used as an index of marrow reserve. There was a loss of 60% of the marrow after 60 mg/M2 of Adr and of 90%o
after 900 mg/M2 of FU. This dose of FU which produces an effect on tumour growth comparable to 60 mg/M2 Adr, causes a much greater depression of the marrow. However, the more pronounced effect of FU upon marrow is not reflected in the decrease in peripheral WBC counts.
The survival studies with 2 injections of Adr separated by various intervals of time were comparable to survival studies after FU. Both studies show that giving the second dose of either agent prior to 11 days results in varying degrees of animal mortality. Giving the second dose of either agent 11 days or more after the first allows the animal to survive. These comparable recovery kinetics after 2 cancer-chemotherapy agents with different mechanisms of action, indicate that this phenomenon is primarily related to the recovery kinetics of the haematopoietic system. The recovery of the gastrointestinal mucosa occurs prior to marrow for either drug. These studies indicate that recovery of the haematopoietic system is one factor to be considered in the design of protocols using Adr.
On the basis of both clinical and experimental studies (Lenaz and Page, 1976 ) the heart is considered to be the dose-limiting organ for accumulated toxicity for Adr. Cardiac dysfunction appears to be a factor in the early deaths reported here after a single dose of Adr of 120 mg/ M2 or 2 divided doses of 60 mg/M2 given 4 or 8 days after the first. Accumulation of fluid was seen in both the pleural and peritoneal cavities at autopsy, suggesting congestive heart failure. However, no specific pathological changes were noted in hearts of animals given 60 mg/M2 of Adr 2-21 days prior to sacrifice. Studies over a 14-week period demonstrated cardiac damage similar to that seen by others in the rat (Mettler et al., 1977) and other species. Vacuoles within mycoardial cells and oedema were prominent after this long interval. In addition, nonspecific changes such as foci of myocardial cell degeneration, occasionally seen in both treated and control rats 2-21 days from start of experiment, were more numerous and prominent in the 14-week animals.
The biochemical results appear to substantiate the pathological findings of slowly increasing cardiac damage over long periods of time. The increased incorporation of DNA precursors into heart DNA is believed to occur mostly in the endothelial cells of the capillaries and in the mitochondria of myocardal fibres (Lenaz and Page, 1976) . Adr induces extensive damage to DNA in cell cultures (Byfield et al., 1977) . The continuous and long-term increased specific activity in heart DNA could also be related to repair of this damage. These studies on depression of DNA synthesis in the rat after a large single dose of Adr are comparable to the findings in the mouse (Young et al., 1975) . The maximum depression of DNAsynthesis occurs between 3 and 6 days in both the rat and mouse, with the DNA synthetic rate returning to control level by Day 9 in the rat. Recovery data are not available for the mouse. The rate of DNA synthesis in the rat heart after both FU (900 mg /m2) and Adr (60 mg/M2) increased to values above controls on Day 11 but returned to control levels by Day 18. The long-term studies showed elevated rates of heart DNA synthesis in rats 3, 8 and 12 weeks after a large single dose of Adr (60 mg /m2) whether i.v., s.c., or i.p. (Table I) . If this long-term increase in specific activity of heart DNA is associated with repair, it would reinforce the pathological observation that cardiac damage is the final stage of a long-term process.
